Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

PURPOSE: Chemotherapy with anthracyclines, taxanes, or alkylating agents often causes cutaneous side effects. Nonspecific inhibition of the proliferative activity of keratinocytes has antidifferentiation effects that lead to defects in the barrier function and, thus, to dry, itchy, and irritable ski...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlrab, Johannes, Bangemann, Nikola, Kleine-Tebbe, Anke, Thill, Marc, Kümmel, Sherko, Grischke, Eva-Maria, Richter, Rainer, Seite, Sophie, Lüftner, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126578/
https://www.ncbi.nlm.nih.gov/pubmed/25114589
http://dx.doi.org/10.2147/BCTT.S61699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126578/
https://www.ncbi.nlm.nih.gov/pubmed/25114589
http://dx.doi.org/10.2147/BCTT.S61699

Ejemplares similares